Arkolith/Insider Trading/IDRA/Form 4

Dougherty Michael R

DirectorIDERA PHARMACEUTICALS, INC. (IDRA) · full profile →Form 4 · filed Oct 5, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 3, 2022Grant(A)59K$0.37$22K342K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-22-010367) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML